Future research should aim to validate the biological relevance of the newly identified risk genes, such as CADM2, and proteins, including MFGE8, DLL1, DPEP1, and HEXIM1, to advance our understanding of IBS pathophysiology further. The gene discussed is CADM2; the disease is irritable bowel syndrome.